EL
ELV
Quarter ended Mar 31, 2023 · FY2023 Q1

Elevance Health (ELV) Revenue — Quarter Ended Mar 31, 2023

Revenue for the quarter increased compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.

Key takeaway

Quarter ended Mar 31, 2023 · FY2023 Q1

Revenue for the quarter increased compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$42.2B

Revenue reported for this quarter.

Quarter-over-quarter

+5.6%

Change from the immediately preceding quarter.

Year-over-year

+10.7%

Change from the comparable year-ago quarter.

Trailing four quarters

$160.7B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jun 30, 2022$38.6B+14.1%
Sep 30, 2022$39.9B+11.5%
Dec 31, 2022$39.9B+9.2%
Mar 31, 2023$42.2B+10.7%

Revenue performance

The reported revenue reflects a sequential increase from the immediately preceding quarter. On a year-over-year basis, revenue was higher than the same quarter one year ago.

Quarterly comparison

Compared with the prior quarter, revenue moved higher. Compared with the same quarter one year earlier, revenue also showed an increase.

What to watch

No filing context was provided to identify specific factors affecting revenue.